C Noel Bairey Merz, HRS 2019 – Women’s Cardiovascular Health
C Noel Bairey Merz (Director of the Barbra Streisand Women’s Heart Center at the Smidt Heart Institute at Cedars-Sinai, CA, USA) discusses the unmet needs in women’s cardiovascular health, including low survival rates following a heart attack and improving the enrolment of women in clinical trials.
Speaker’s disclosures: C Noel Bairey Merz has received honoraria and consultancy fees from ACRWH (NIH advisory council), NIH-CASE (grant review study section), book honoraria from Springer International and Decision Support in Medicine LLC and is a board director for iRhythm. She has also received honoraria and consultancy fees to Cedars-Sinai Medical Center from American College of OB-GYN, Atlantic Health System, Abbott Diagnostics, American College of Cardiology, Cardio NAH Health System, Expert Exchange, INOVA, George Washington University, Med Ed, Northwestern, Pri-Med, Oklahoma Chapter of the American College of Cardiology, Renown Health System, Reno, San Diego Heart Institute, Society of Vascular Medicine, St Francis Medical Center, Hartford, University of Minnesota, UCSF, University of Capetown, University of Colorado.
- What are the major unmet needs in women’s cardiovascular health? (0:09)
- What reasons have been identified for the lower heart attack survival rates in women compared to men? (0:55)
- How can we improve the enrolment of women in clinical trials? (2:07)
- What treatment options are available for women with ischemia with no obstructive coronary artery disease? (4:30)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed in partnership with Arrhythmia Alliance.
Share this Video
Related Videos In Cardiovascular Disease
John Forrest, ACC 2023: Evolut low risk trial, transcatheter versus surgical aortic valve replacement in patients at low surgical risk
The Evolut low risk trial aimed to compare transcatheter versus surgical aortic valve replacement in patients who were at low risk for surgery. In this touchCARDIO interview, we speak with Dr John Forrest (Yale New Haven Hospital, Yale University, New Haven, CT, USA) to discuss the eligibility criteria, the key findings and the outlook for […]
John Forrest, ACC 2023: The treatment paradigm for patients with aortic stenosis
The treatment paradigm for aortic stenosis has developed dramatically in the past decade. In this touchCARDIO interview, we speak with Dr John Forrest (Yale New Haven Hospital, Yale University, New Haven, CT, USA) to outline and discuss the developments. Dr Forrest presented an abstract entitled ‘Transcatheter Versus Surgical Aortic Valve Replacement In Aortic Stenosis Patients […]
Steven Nissen, ACC 2023: Lipid-lowering therapies – current and future options
Many lipid-lowering therapies exist, such as statins to manage and reduce lipid levels. While statins are the most commonly used medication, some patients may need additional interventions to lower their LDL cholesterol levels. In this touchCARDIO interview, we speak with Prof. Steven Nissen (Cleveland Clinic, Cleveland, OH, USA) to explore current and developing novel lipid-lowering […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!